Finance

Lists
Why is NKTX down 5.93%?
Dive Deeper
NKTX:NASDAQ
Nkarta Inc
$1.19
-5.93%
(-0.075) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKTX...
Open
$1.28
High
$1.31
Low
$1.10
Mkt. cap
85.33M
Avg. vol.
1.41M
Volume
1.41M
52-wk high
$3.72
52-wk low
$1.10
EPS
-$1.73
Beta
1.24
Shares outstanding
71.70M
No. of employees
103
Open
$1.28
High
$1.31
Low
$1.10
Mkt. cap
85.33M
Avg. vol.
1.41M
Volume
1.41M
52-wk high
$3.72
52-wk low
$1.10
EPS
-$1.73
Beta
1.24
Shares outstanding
71.70M
No. of employees
103
News stories
From web sources and news partners
About Nkarta Inc
CEO-
Employees103
Founded2015
HeadquartersSouth San Francisco, California, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to NKTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for NKTX in the last 3 months.
Highest
Current $1.19
$12.00 (+908.40%)
Average
$11.25 (+845.38%)
Lowest
$10.00 (+740.34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$12.00
+908.4%
11/10/2026
Stephen Willey
Stifel Nicolaus
Buy
Reiterated
$10.00
+740.3%
11/06/2026
Emily Bodnar
H.C. Wainwright
Buy
Initiated
$12.00
+908.4%
11/02/2026
Gil Blum
Needham
Buy
Maintained
$11.00
+824.4%
10/05/2026
Salim Syed
Mizuho Securities
Buy
Maintained
$12.00
+908.4%
08/17/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
08/10/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
$9.00
+656.3%
05/18/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
03/26/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
-$0.45 / -$0.38
-17.39%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
25.28M
24.99M
29.05M
29.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.31M
5.89M
6.03M
6.31M
Operating expense
30.59M
30.88M
35.08M
35.78M
Total operating expenses
30.59M
30.88M
35.08M
35.78M
Operating income
-30.59M
-30.88M
-35.08M
-35.78M
Other non operating income
162.00K
206.00K
222.00K
206.00K
EBT including unusual items
-27.41M
-27.83M
-40.37M
-33.33M
EBT excluding unusual items
-27.14M
-27.83M
-32.32M
-33.33M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-27.41M
-27.83M
-40.37M
-33.33M
Net profit margin
-
-
-
-
Earnings per share
-0.37
-0.37
-0.54
-0.45
Interest and investment income
3.30M
2.84M
2.54M
2.24M
Interest expense
-
-
-
-
Net interest expenses
3.30M
2.84M
2.54M
2.24M
Depreciation and amortization charges
-
-
-
-
EBITDA
-28.34M
-28.54M
-32.35M
-33.72M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps